PCSK1N and Parkinson disease: In a recent study involving 32 participants (9 idiopathic PD patients, 13 PD patients with pathogenic biallelic PRKN variants, and 10 healthy controls), Kluge et al. evaluated the prevalence of α-Syn seeding activity by blood-based α-Syn SAAs [40].